Key result
Multi-arterial grafting is a safe procedure for myocardial revascularization, as choice of conduit was not a predictor of operative mortality or morbidity by multivariate analysis.
Why the study?
Does multi-arterial grafting compared to single arterial or venous grafting affect operative mortality and morbidity in patients undergoing myocardial revascularization?
Cohort (n=3,062)
Does multi-arterial grafting compared to single arterial or venous grafting affect operative mortality and morbidity in patients undergoing myocardial revascularization?
Multi-arterial grafting is a safe and efficacious procedure for myocardial revascularization in carefully selected patients, without independently increasing operative mortality or morbidity compared to conventional conduits.
Answers are grounded in this paper and cite their sources.
Supports multi-arterial grafting safety in selected patients; leaves open randomized confirmation of outcomes.
To assess the efficacy of arterial revascularization 368 patients were studied who underwent myocardial revascularization with two or more arterial conduits (group M) and compared with 2092 patients in whom a single internal mammary artery ± veins (group S), and to a third group in which only saphenous vein conduits (group V, n = 602) were used. Group M patients were younger (aged 54.0(9.5) years: 4.1% aged > 70 years) than either group V (67.6(8.9) years, 40.7% > 70 years, P < 0.0001) or group S patients (62.0(8.5) years. 15.7% > 70 years, P < 0.0001). Furthermore, this cohort group had the lowest percentage of females (8.4%), of urgent cases (21.7%), of preoperative myocardial infarction (6.0%), and of redo surgery (0.8%). In contrast, patients who received only saphenous vein conduits had the highest proportion of female patients (29.2%), of urgent cases (47.4%), of preoperative myocardial infarction (16.5%), and of redo surgery (5.5%). By multivariate logistic regression analysis (odds ratio in parentheses), redo surgery (6.06, P = 0.0001), preoperative intra-aortic balloon pump assist (6.11, P = 0.0001), diabetes (1.97, P = 0.03), urgent surgery (1.80, P = 0.05), and advanced age (2.14, P = 0.01) were all predictors of operative mortality. In contrast, while choice of conduit appeared to influence outcome by univariate analysis (4.2% mortality in group V, P < 0.001), it was not found to be a predictor of either mortality or morbidity by regression analysis. The present results indicate that, in carefully selected patients, despite increased technical demands with longer periods of aortic occlusion and longer pump times, multi-arterial grafting (compared with conventional revascularization) is a safe and efficacious procedure. Whether or not this approach to revascularization will increase long-term survival and freedom from reoperation will require further study.
No takes yet. Share an insight, caveat, or question.
Rizzo et al. (1998) conducted a cohort in Myocardial revascularization (n=3,062). Multi-arterial grafting (two or more arterial conduits) vs. Single internal mammary artery ± veins, or only saphenous vein conduits was evaluated on Operative mortality (p=<0.001). Multi-arterial grafting is a safe procedure for myocardial revascularization, as choice of conduit was not a predictor of operative mortality or morbidity by multivariate analysis.
Synapse has enriched 10 related papers. Consider them for comparative context: